U.S. Food and Drug Administration has granted PhysioSonics' Presto 1000 Flow Monitor system 510k clearance for cranial blood flow monitoring. In addition, the company has completed of Series B add-on debt financing, closing with $1.05 million.
The Presto 1000 Flow Monitor is designed to allow any clinician to perform mid cerebral cranial blood flow monitoring, freeing institutions to more efficiently deploy sonographers who are required less often for the system. It is also designed to replace periodic measurement with continuous monitoring.
PhysioSonics uses its proprietary "Flash" Doppler for the monitoring functions. The addition of Flash, with the transducers attached to headset, assists in locating and maintaining the flow of information from mid cerebral arteries.
The company has 33 U.S. and foreign patents covering its technology. It has been the recipient of DARPA and NIH funding to use PhysioSonics technology to study head trauma, traumatic brain injury and bi-lateral flow monitoring.
Latest from Today's Medical Developments
- Meet the minds shaping CNC grinding at The Precision Summit
- Mitutoyo unveils innovative SurfaceMeasure-S Series sensors
- #69 Manufacturing Matters - Shopfloor Connectivity Roundtable with Renishaw and SMW Autoblok
- Veeva's impact on compliance and efficiency in medtech
- Demystifying Controlled Unclassified Information (CUI)
- Streamline design with Festo's engineering tools
- Simplify your shop floor operations while ensuring quality parts
- Happy Independence Day - July 4th